Skip to main content

Advertisement

Log in

5-HT7 Receptors Are Involved in Neurogenic Dural Vasodilatation in an Experimental Model of Migraine

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Neurogenic dural vasodilation has been demonstrated to play an important role in migraine. 5-HT7 receptors have been found on trigeminal nerve endings and middle meningeal arteries and demonstrated involved in the dilatation of meningeal arteries. The aim of the present study was to demonstrate whether 5-HT7 receptors are involved in neurogenic dural vasodilation in migraine. The neurogenic dural vasodilation model of migraine was used in this study. Unilateral electrical stimulation of dura mater was performed in anesthetized male Sprague–Dawley rats. Animals were pretreated with selective 5-HT7 receptor agonist AS19, 5-HT7 receptor antagonist SB269970, 5-HT1B/1D receptor agonist sumatriptan, or vehicles. Blood flow of the middle meningeal artery (MMA) was measured by a laser Doppler flowmetry. AS19 significantly increased the basal and stimulated blood flows of the middle meningeal artery following electrical stimulation of dura mater, and its effect was dose dependent at the early stage. SB269970 and sumatriptan significantly reduced the basal and stimulated blood flows of middle meningeal artery. The present study demonstrates for the first time that 5-HT7 receptors are involved in neurogenic dural vasodilation evoked by electrical stimulation of dura mater and maybe of relevance in the pathophysiology and treatment of migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ANOVA:

Analysis of variance

AS19:

(2S)-(+)-5-(1, 3, 5- Trimethylpyrazol-4-yl)-2-(dimethylamino) tetralin

BI:

Baseline

CGRP:

Calcitonin gene-related peptide

DMSO:

Dimethyl sulfoxide

LSD:

Fisher’s least significance difference

NS:

Normal saline

MMA:

Middle meningeal artery

SB269970:

(2R)-1-[(3-Hydroxyphenyl) sulfonyl]-2-[2-(4-methyl-1-piperidinyl) ethyl] pyrrolidine hydrochloride

TRPV1:

Transient receptor potential vanilloid 1

References

  • Akerman S, Williamson DJ, Hill RG, Goadsby PJ (2001) The effect of adrenergic compounds on neurogenic dural vasodilatation. Eur J Pharmacol 424:53–58

    Article  CAS  PubMed  Google Scholar 

  • Andreou AP, Holland PR, Goadsby PJ (2009) Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation. Br J Pharmacol 157:464–473

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bourson A, Kapps V, Zwingelstein C, Rudler A, Boess FG, Sleight AJ (1997) Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2 J mice. Naunyn-Schmiedeberg’s Arch Pharmacol 356:820–826

    Article  CAS  Google Scholar 

  • Brenchat A, Romero L, García M, Pujol M, Burgueño J, Torrens A et al (2009) 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain 141:239–247

    Article  CAS  PubMed  Google Scholar 

  • De Vries P, Sanchez-Lopez A, Centurion D, Heiligers JP, Saxena PR, Villalón CM (1998) The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists. Eur J Pharmacol 362:69–72

    Article  PubMed  Google Scholar 

  • De Vries P, Willems EW, Heiligers JP, Villalón CM, Saxena PR (1999) Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses. Br J Pharmacol 127:405–412

    Article  PubMed Central  PubMed  Google Scholar 

  • Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668–1675

    Article  CAS  PubMed  Google Scholar 

  • Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine—current understanding and treatment. N Engl J Med 346:257–270

    Article  CAS  PubMed  Google Scholar 

  • Graf M, Jakus R, Kantor S, Levay G, Bagdy G (2004) Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci Lett 359:45–48

    Article  CAS  PubMed  Google Scholar 

  • Hargreaves R (2007) New migraine and pain research. Headache 47:S26–S43

    Article  PubMed  Google Scholar 

  • Hedlund PB, Sutcliffe JG (2004) Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 25:481–486

    Article  CAS  PubMed  Google Scholar 

  • Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG (2005) 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry 58:831–837

    Article  CAS  PubMed  Google Scholar 

  • Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X et al (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 372:2115–2123

    Article  CAS  PubMed  Google Scholar 

  • Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554

    Article  CAS  PubMed  Google Scholar 

  • Kobe F, Guseva D, Jensen TP, Wirth A, Renner U, Hess D et al (2012) 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci 32:2915–2930

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kurosawa M, Messlinger K, Pawlak M, Schmidt RF (1995) Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 114:1397–1402

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lipton RB, Bigal ME (2008) Toward an epidemiology of refractory migraine: current knowledge and issues for future research. Headache 48:791–798

    Article  PubMed  Google Scholar 

  • Mahé C, Loetscher E, Dev KK, Bobirnac I, Otten U, Schoeffter P (2005) Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. Neuropharmacology 49:40–47

    Article  PubMed  Google Scholar 

  • Martín-Cora FJ, Pazos A (2004) Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H] mesulergine: comparison to other mammalian species. Br J Pharmacol 141:92–104

    Article  PubMed Central  PubMed  Google Scholar 

  • Nicoletti P, Trevisani M, Manconi M, Gatti R, De Siena G, Zagli G et al (2008) Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia 28:9–17

    Article  CAS  PubMed  Google Scholar 

  • Pericić D, Svob Strac D (2007) The role of 5-HT7 receptors in the control of seizures. Brain Res 1141:48–55

    Article  PubMed  Google Scholar 

  • Schmuck K, Ullmer C, Kalkman HO, Probst A, Lubbert H (1996) Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache? Eur J Neurosci 8:959–967

    Article  CAS  PubMed  Google Scholar 

  • Storer RJ, Akerman S, Goadsby PJ (2004) Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 142:1171–1181

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tepper SJ, Rapoport AM, Sheftell FD (2002) Mechanisms of action of the 5-HT1B/1D receptor agonists. Arch Neurol 59:1084–1088

    Article  PubMed  Google Scholar 

  • Terrón JA, Martínez-García E (2007) 5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats. Eur J Pharmacol 560:56–60

    Article  PubMed Central  PubMed  Google Scholar 

  • Terrón JA, Bouchelet I, Hamel E (2001) 5-HT7 receptor mRNA expression in human trigeminal ganglia. Neurosci Lett 302:9–12

    Article  PubMed  Google Scholar 

  • Tröltzsch M, Denekas T, Messlinger K (2007) The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow. Eur J Pharmacol 562:103–110

    Article  PubMed  Google Scholar 

  • Wang X, Fang Y, Liang J, Yin Z, Miao J, Luo N (2010) Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine. Headache 50:579–587

    Article  PubMed  Google Scholar 

  • Wesołowska A, Nikiforuk A, Stachowicz K, Tatarczyńska E (2006) Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51:578–586

    Article  PubMed  Google Scholar 

  • Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL (1997) Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat–intravital microscope studies. Cephalalgia 17:525–531

    Article  CAS  PubMed  Google Scholar 

  • Williamson DJ, Hill RG, Shepheard SL, Hargreaves RJ (2001a) The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs. Br J Pharmacol 133:1029–1034

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Williamson DJ, Shepheard SL, Cook DA, Hargreaves RJ, Hill RG, Cumberbatch MJ (2001b) Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats. Br J Pharmacol 133:807–814

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M et al (2010) Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways. Anesthesiology 112:696–710

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Natural Science Foundation of China (grant numbers 81100830, 81171101) and the Medical Science and Technology Project of Guangzhou (grant number 20121A011025).

Conflict of Interest

There is no conflict of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaoping Pan.

Additional information

Xiaojuan Wang, Yannan Fang and Jianbo Liang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, X., Fang, Y., Liang, J. et al. 5-HT7 Receptors Are Involved in Neurogenic Dural Vasodilatation in an Experimental Model of Migraine. J Mol Neurosci 54, 164–170 (2014). https://doi.org/10.1007/s12031-014-0268-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-014-0268-9

Keywords

Navigation